Medicare Enrolled

Dr. Angela Kulesza, F.N.P.

Nurse Practitioner - Family · Tewksbury, MA
Low-engagement
600 CLARK RD, Tewksbury, MA 01876
9784586900
In practice since 2006 (20 years)
NPI: 1235107210 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kulesza from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kulesza? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kulesza

Dr. Angela Kulesza is a nurse practitioner - family in Tewksbury, MA, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Kulesza received a total of $13,218 from 49 pharmaceutical and/or device companies across 506 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kulesza is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice $13,218 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$13,218
Total received (2021-2024)
Avg $3,304/year across 4 years
Top 1% in MA for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
506
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,590 (65.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,627 (35.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,023
2023
$2,338
2022
$2,262
2021
$6,595

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$402
PFIZER INC.
$301
Bayer Healthcare Pharmaceuticals Inc.
$257
ABBVIE INC.
$224
Otsuka America Pharmaceutical, Inc.
$151
Abbott Laboratories
$110
Amgen Inc.
$84
Lilly USA, LLC
$83
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$76
E.R. Squibb & Sons, L.L.C.
$71
Novo Nordisk Inc
$52
GlaxoSmithKline, LLC.
$35
Exact Sciences Corporation
$34
Philips North America LLC
$27
Astellas Pharma US Inc
$22
SHIELD THERAPEUTICS INC
$21
Mylan Specialty L.P.
$20
Merck Sharp & Dohme LLC
$19
Inspire Medical Systems, Inc.
$18
Alkermes, Inc.
$17
Top 3 companies account for 47.4% of 2024 payments
All-time payments by company (2021-2024) ›
Biohaven Pharmaceuticals, Inc.
$4,526
ABBVIE INC.
$1,131
PFIZER INC.
$1,029
AstraZeneca Pharmaceuticals LP
$970
Bayer Healthcare Pharmaceuticals Inc.
$571
E.R. Squibb & Sons, L.L.C.
$399
Novo Nordisk Inc
$387
GlaxoSmithKline, LLC.
$282
Merck Sharp & Dohme LLC
$281
Astellas Pharma US Inc
$267
Amgen Inc.
$262
Lilly USA, LLC
$243
Otsuka America Pharmaceutical, Inc.
$219
AbbVie Inc.
$213
Lundbeck LLC
$176
RedHill Biopharma Inc.
$156
Takeda Pharmaceuticals U.S.A., Inc.
$153
Alkermes, Inc.
$151
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$140
Abbott Laboratories
$125
Merck Sharp & Dohme Corporation
$123
Sage Therapeutics, Inc.
$120
Teva Pharmaceuticals USA, Inc.
$116
Amarin Pharma Inc.
$98
IMPEL PHARMACEUTICALS INC.
$96
SANOFI-AVENTIS U.S. LLC
$90
Boehringer Ingelheim Pharmaceuticals, Inc.
$87
Antares Pharma, Inc.
$82
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$76
Exact Sciences Corporation
$74
Bayer HealthCare Pharmaceuticals Inc.
$63
Philips Electronics North America Corporation
$56
SK Life Science, Inc.
$48
Corium, LLC
$48
Neurocrine Biosciences, Inc.
$40
Esperion Therapeutics, Inc.
$35
kaleo, Inc.
$33
Collegium Pharmaceutical, Inc.
$30
Shield Therapeutics Inc
$28
Philips North America LLC
$27
SHIELD THERAPEUTICS INC
$21
Ultragenyx Pharmaceutical Inc.
$20
Mylan Specialty L.P.
$20
Daiichi Sankyo Inc.
$19
IDORSIA PHARMACEUTICALS US INC
$19
Inspire Medical Systems, Inc.
$18
Paratek Pharmaceuticals, Inc.
$17
Novartis Pharmaceuticals Corporation
$17
Janssen Pharmaceuticals, Inc
$12
Top 3 companies account for 50.6% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACCRUFER · AIRSUPRA · AJOVY · ANORO ELLIPTA · ARALAST · AREXVY · ARISTADA · AUVI-Q · Aimovig · Azstarys · BELSOMRA · BREZTRI · BRILINTA · CAMZYOS · CAPLYTA · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CREON · Cologuard Collection Kit · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FREESTYLE LIBRE 3 · GARDASIL · GARDASIL 9 · INGREZZA · INJECTAFER · INSPIRE · JANUMET · JANUVIA · JARDIANCE · Kerendia · LINZESS · LYBALVI · MOUNJARO · MYRBETRIQ · Movantik · Myrbetriq · NEXLETOL · NEXLIZET · NOCDURNA · NURTEC ODT · NUZYRA · Otezla · Ozempic · PREMARIN · PREVNAR 13 · PREVNAR 20 · QULIPTA · QUVIVIQ · RELISTOR · REXULTI · RYBELSUS · Rybelsus · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · SYMBICORT · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TRUMENBA · Talicia · Trudhesa · UBRELVY · VIBERZI · VRAYLAR · VYVANSE · Vascepa · Veozah · XARELTO · XCOPRI · XIFAXAN · XTAMPZA · YUPELRI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (65%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for nurse practitioner - family in MA.

Looking for a nurse practitioner - family in Tewksbury?
Compare family nurse practitioners in the Tewksbury area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners within 10 mi
2,359
Per 100K population
145.4
County median income
$126,779
Nearest hospital
LOWELL GENERAL HOSPITAL
6.7 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kulesza is a nurse practitioner - family, with low-engagement industry engagement in the top 1% of MA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Kulesza receive payments from pharmaceutical companies?
Yes. Dr. Kulesza received a total of $13,218 from 49 companies across 506 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Kulesza) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Family Nurse Practitioners in Tewksbury
Browse family nurse practitioners in Tewksbury ranked by procedure volume and transparency data.
Highest volume
Top Family Nurse Practitioners in MA
Family nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Nurse Practitioners in MA
Which MA family nurse practitioners receive the most from drug and device companies.
By company
Biohaven Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceuticals, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →